[PDF][PDF] Damage-associated molecular patterns in inflammatory diseases
JS Roh, DH Sohn - Immune network, 2018 - synapse.koreamed.org
Damage-associated molecular patterns (DAMPs) are endogenous danger molecules that
are released from damaged or dying cells and activate the innate immune system by …
are released from damaged or dying cells and activate the innate immune system by …
A systemic view of Alzheimer disease—insights from amyloid-β metabolism beyond the brain
Alzheimer disease (AD) is the most common type of dementia, and is currently incurable;
existing treatments for AD produce only a modest amelioration of symptoms. Research into …
existing treatments for AD produce only a modest amelioration of symptoms. Research into …
[HTML][HTML] Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment
The prevalence of cerebrovascular disease increases with age, placing the elderly at a
greater lifetime risk for dementia. Vascular cognitive impairment (VCI) encompasses a …
greater lifetime risk for dementia. Vascular cognitive impairment (VCI) encompasses a …
[HTML][HTML] Role of S100 proteins in health and disease
LL Gonzalez, K Garrie, MD Turner - Biochimica et Biophysica Acta (BBA) …, 2020 - Elsevier
The S100 family of proteins contains 25 known members that share a high degree of
sequence and structural similarity. However, only a limited number of family members have …
sequence and structural similarity. However, only a limited number of family members have …
Astrocyte biomarkers in Alzheimer's disease
Astrocytic contributions to Alzheimer's disease (AD) progression were, until recently, largely
overlooked. Astrocytes are integral to normal brain function and astrocyte reactivity is an …
overlooked. Astrocytes are integral to normal brain function and astrocyte reactivity is an …
Alzheimer's disease pathogenesis: Role of autophagy and mitophagy focusing in microglia
M Eshraghi, A Adlimoghaddam… - International Journal of …, 2021 - mdpi.com
Alzheimer's disease (AD) is a debilitating neurological disorder, and currently, there is no
cure for it. Several pathologic alterations have been described in the brain of AD patients …
cure for it. Several pathologic alterations have been described in the brain of AD patients …
Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis
Objective To perform a systematic review and meta-analysis to determine whether fluid and
imaging astrocyte biomarkers are altered in Alzheimer disease (AD). Methods PubMed and …
imaging astrocyte biomarkers are altered in Alzheimer disease (AD). Methods PubMed and …
New insights into the role of neuron-specific enolase in neuro-inflammation, neurodegeneration, and neuroprotection
A Haque, R Polcyn, D Matzelle, NL Banik - Brain sciences, 2018 - mdpi.com
Neurodegeneration is a complex process that leads to irreversible neuronal damage and
death in spinal cord injury (SCI) and various neurodegenerative diseases, which are …
death in spinal cord injury (SCI) and various neurodegenerative diseases, which are …
S100 proteins in Alzheimer's disease
S100 proteins are calcium-binding proteins that regulate several processes associated with
Alzheimer's disease (AD) but whose contribution and direct involvement in disease …
Alzheimer's disease (AD) but whose contribution and direct involvement in disease …
Danger-associated molecular patterns in Alzheimer's disease
C Venegas, MT Heneka - Journal of Leucocyte Biology, 2017 - academic.oup.com
Pathogen-associated molecular patterns (PAMPs) and endogenous “danger” signals,
known as danger-associated molecular patterns (DAMPs), released from cells alert the …
known as danger-associated molecular patterns (DAMPs), released from cells alert the …